News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Commissioner Defends Zogenix, Inc. (ZGNX)'s Pain Drug As Criticism Intensifies



3/14/2014 7:55:57 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Debate over a powerful new painkiller ratcheted up Thursday as the head of the Food and Drug Administration defended the drug's approval and a West Virginia Senator responded with a bill to force it off the market. FDA Commissioner Dr. Margaret Hamburg told Senate lawmakers that the recently-launched Zohydro fills an "important and unique niche" for treating chronic pain. Her agency has been under fire for clearing the drug since December, amid concerns from lawmakers, addiction specialists and others that the drug will exacerbate the national epidemic of prescription drug abuse.

Help employers find you! Check out all the jobs and post your resume.

Read at Boston Herald
Read at ABC News
Read at Forbes
Read at NBC
Read at Reuters


comments powered by Disqus
Boston Herald
ABC News
Forbes
NBC
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES